MCRB
Price
$0.59
Change
-$0.00 (-0.00%)
Updated
Nov 14 closing price
116 days until earnings call
RIGL
Price
$27.46
Change
+$0.05 (+0.18%)
Updated
Nov 14 closing price
Ad is loading...

MCRB vs RIGL

Header iconMCRB vs RIGL Comparison
Open Charts MCRB vs RIGLBanner chart's image
Seres Therapeutics
Price$0.59
Change-$0.00 (-0.00%)
Volume$2.02M
CapitalizationN/A
Rigel Pharmaceuticals
Price$27.46
Change+$0.05 (+0.18%)
Volume$352.47K
CapitalizationN/A
MCRB vs RIGL Comparison Chart
Loading...
MCRB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
MCRB vs. RIGL commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCRB is a Hold and RIGL is a StrongBuy.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (MCRB: $0.59 vs. RIGL: $27.46)
Brand notoriety: MCRB and RIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MCRB: 56% vs. RIGL: 164%
Market capitalization -- MCRB: $100.78M vs. RIGL: $483.71M
MCRB [@Biotechnology] is valued at $100.78M. RIGL’s [@Biotechnology] market capitalization is $483.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MCRB’s FA Score shows that 0 FA rating(s) are green whileRIGL’s FA Score has 0 green FA rating(s).

  • MCRB’s FA Score: 0 green, 5 red.
  • RIGL’s FA Score: 0 green, 5 red.
According to our system of comparison, RIGL is a better buy in the long-term than MCRB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MCRB’s TA Score shows that 3 TA indicator(s) are bullish while RIGL’s TA Score has 5 bullish TA indicator(s).

  • MCRB’s TA Score: 3 bullish, 4 bearish.
  • RIGL’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, RIGL is a better buy in the short-term than MCRB.

Price Growth

MCRB (@Biotechnology) experienced а -17.21% price change this week, while RIGL (@Biotechnology) price change was +77.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.07%. For the same industry, the average monthly price growth was +3.27%, and the average quarterly price growth was +5.23%.

Reported Earning Dates

MCRB is expected to report earnings on Mar 11, 2025.

RIGL is expected to report earnings on Aug 06, 2024.

Industries' Descriptions

@Biotechnology (-2.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RIGL($484M) has a higher market cap than MCRB($101M). RIGL YTD gains are higher at: 89.379 vs. MCRB (-57.707).
MCRBRIGLMCRB / RIGL
Capitalization101M484M21%
EBITDAN/AN/A-
Gain YTD-57.70789.379-65%
P/E RatioN/A101.70-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/A60.5M-
FUNDAMENTALS RATINGS
MCRB vs RIGL: Fundamental Ratings
MCRB
RIGL
OUTLOOK RATING
1..100
6431
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
89
Overvalued
PROFIT vs RISK RATING
1..100
10073
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9234
P/E GROWTH RATING
1..100
10066
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MCRB's Valuation (72) in the Biotechnology industry is in the same range as RIGL (89). This means that MCRB’s stock grew similarly to RIGL’s over the last 12 months.

RIGL's Profit vs Risk Rating (73) in the Biotechnology industry is in the same range as MCRB (100). This means that RIGL’s stock grew similarly to MCRB’s over the last 12 months.

RIGL's SMR Rating (100) in the Biotechnology industry is in the same range as MCRB (100). This means that RIGL’s stock grew similarly to MCRB’s over the last 12 months.

RIGL's Price Growth Rating (34) in the Biotechnology industry is somewhat better than the same rating for MCRB (92). This means that RIGL’s stock grew somewhat faster than MCRB’s over the last 12 months.

RIGL's P/E Growth Rating (66) in the Biotechnology industry is somewhat better than the same rating for MCRB (100). This means that RIGL’s stock grew somewhat faster than MCRB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MCRBRIGL
RSI
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
N/A
Bullish Trend 1 day ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
80%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Ad is loading...
MCRB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

MCRB and

Correlation & Price change

A.I.dvisor indicates that over the last year, MCRB has been loosely correlated with RIGL. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if MCRB jumps, then RIGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MCRB
1D Price
Change %
MCRB100%
+0.32%
RIGL - MCRB
38%
Loosely correlated
+0.18%
ATNM - MCRB
37%
Loosely correlated
-3.51%
OTLK - MCRB
32%
Poorly correlated
-7.55%
ARCT - MCRB
30%
Poorly correlated
-4.38%
RCKT - MCRB
30%
Poorly correlated
-5.42%
More

RIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RIGL has been closely correlated with CLNN. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if RIGL jumps, then CLNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RIGL
1D Price
Change %
RIGL100%
+0.18%
CLNN - RIGL
92%
Closely correlated
-2.70%
HOOK - RIGL
91%
Closely correlated
-8.19%
DARE - RIGL
88%
Closely correlated
-7.04%
PHIO - RIGL
84%
Closely correlated
-5.11%
AZTR - RIGL
84%
Closely correlated
-7.90%
More